Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |